Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: A mouse model of type 3 familial hemophagocytic lymphohistiocytosis

Journal of Experimental Medicine

Volumn 204, Issue 4, 2007, Pages 853-863

  Crozat, Karine ^a   Hoebe, Kasper ^a   Ugolini, Sophie ^b,c,d   Hong, Nancy A ^e   Janssen, Edith ^f   Rutschmann, Sophie ^a,g   Mudd, Suzanne ^a   Sovath, Sosathya ^a   Vivier, Eric ^b,c,d   Beutler, Bruce ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c INSERM   (France)

^d CNRS   (France)

^e Phenomix Corporation   (United States)

^f LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLNITROSOUREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 11; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; GENE; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; JINX GENE; MEIOSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING; T LYMPHOCYTE; UNC13D GENE;

ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HERPESVIRIDAE INFECTIONS; INTERFERON TYPE II; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MEMBRANE PROTEINS; MICE; MUROMEGALOVIRUS; MUTATION; PHENOTYPE;

EID: 34247353624     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062447     Document Type: Article

References (53)

1. Arase, H., E.S. Mocarski, A.E. Campbell, A.B. Hill, and L.L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:1323-1326.
2. Lee, S.H., S. Girard, D. Macina, M. Busa, A. Zafer, A. Belouchi, P. Gros, and S.M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:42-45.
3. Lee, S.H., A. Zafer, Y. de Repentigny, R. Kothary, M.L. Tremblay, P. Gros, P. Duplay, J.R. Webb, and S.M. Vidal. 2003. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. 197:515-526.
4. Brown, M.G., A.O. Dokun, J.W. Heusel, H.R. Smith, D.L. Beckman, E.A. Blattenberger, C.E. Dubbelde, L.R. Stone, A.A. Scalzo, and W.M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 292:934-937.
5. Crozat, K., P. Georgel, S. Rutschmann, N. Mann, X. Du, K. Hoebe, and B. Beutler. 2006. Analysis of the MCMV resistome by ENU mutagenesis. Mamm. Genome. 17:398-406.
6. Beutler, B., K. Crozat, J.A. Koziol, and P. Georgel. 2005. Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model. Curr. Opin. Immunol. 17:36-43.
7. Delale, T., A. Paquin, C. Asselin-Paturel, M. Dalod, G. Brizard, E.E. Bates, P. Kastner, S. Chan, S. Akira, A. Vicari, et al. 2005. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. J. Immunol. 175:6723-6732.
8. Krug, A., A.R. French, W. Barchet, J.A. Fischer, A. Dzionek, J.T. Pingel, M.M. Orihuela, S. Akira, W.M. Yokoyama, and M. Colonna. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity. 21:107-119.
9. Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA. 101:3516-3521.
10. Tabeta, K., K. Hoebe, E.M. Janssen, X. Du, P. Georgel, K. Crozat, S. Mudd, N. Mann, S. Sovath, J. Goode, et al. 2006. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7:156-164.
11. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S.O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424:743-748.
12. Sjolin, H., E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Karre, E. Vivier, and C. Cerboni. 2002. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195:825-834.
13. Presti, R.M., J.L. Pollock, A.J. Dal Canto, A.K. O'Guin, and H.W. Virgin IV. 1998. Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:577-588.
14. Pien, G.C., A.R. Satoskar, K. Takeda, S. Akira, and C.A. Biron. 2000. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J. Immunol. 165:4787-4791.
15. Salazar-Mather, T.P., C.A. Lewis, and C.A. Biron. 2002. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J. Clin. Invest. 110:321-330.
16. Salazar-Mather, T.P., and K.L. Hokeness. 2003. Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/ chemokine networks. Viral Immunol. 16:291-306.
17. Strobl, B., I. Bubic, U. Bruns, R. Steinborn, R. Lajko, T. Kolbe, M. Karaghiosoff , U. Kalinke, S. Jonjic, and M. Muller. 2005. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. J. Immunol. 175:4000-4008.
18. Durbin, J.E., R. Hackenmiller, M.C. Simon, and D.E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84:443-450.
19. Lee, C.K., D.T. Rao, R. Gertner, R. Gimeno, A.B. Frey, and D.E. Levy. 2000. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165:3571-3577.
20. Nguyen, K.B., T.P. Salazar-Mather, M.Y. Dalod, J.B. Van Deusen, X.Q. Wei, F.Y. Liew, M.A. Caligiuri, J.E. Durbin, and C.A. Biron. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279-4287.
21. Shellam, G.R., J.E. Allan, J.M. Papadimitriou, and G.J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA. 78:5104-5108.
22. Loh, J., D.T. Chu, A.K. O'Guin, W.M. Yokoyama, and H.W. Virgin IV. 2005. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79:661-667.
23. Haddad, E.K., X. Wu, J.A. Hammer III, and P.A. Henkart. 2001. Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J. Cell Biol. 152:835-842.
24. Stinchcombe, J., G. Bossi, and G.M. Griffiths. 2004. Linking albinism and immunity: the secrets of secretory lysosomes. Science. 305:55-59.
25. Rubio, V., T.B. Stuge, N. Singh, M.R. Betts, J.S. Weber, M. Roederer, and P.P. Lee. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9:1377-1382.
26. Alter, G., J.M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods. 294:15-22.
27. Feldmann, J., I. Callebaut, G. Raposo, S. Certain, D. Bacq, C. Dumont, N. Lambert, M. Ouachee-Chardin, G. Chedeville, H. Tamary, et al. 2003. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 115:461-473.
28. Marcenaro, S., F. Gallo, S. Martini, A. Santoro, G.M. Griffiths, M. Arico, L. Moretta, and D. Pende. 2006. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood. 108:2316-2323.
29. Stepp, S.E., R. Dufourcq-Lagelouse, F. Le Deist, S. Bhawan, S. Certain, P.A. Mathew, J.I. Henter, M. Bennett, A. Fischer, G. de Saint Basile, and V. Kumar. 1999. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 286:1957-1959.
30. zur Stadt, U., S. Schmidt, B. Kasper, K. Beutel, A.S. Diler, J.I. Henter, H. Kabisch, R. Schneppenheim, P. Nurnberg, G. Janka, and H.C. Hennies. 2005. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum. Mol. Genet. 14:827-834.
31. Menasche, G., E. Pastural, J. Feldmann, S. Certain, F. Ersoy, S. Dupuis, N. Wulffraat, D. Bianchi, A. Fischer, F. Le Deist, and G. de Saint Basile. 2000. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat. Genet. 25:173-176.
32. Rubin, C.M., B.A. Burke, R.W. McKenna, K.L. McClain, J.G. White, M.E. Nesbit Jr., and A.H. Filipovich. 1985. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer. 56:524-530.
33. Fisman, D.N. 2000. Hemophagocytic syndromes and infection. Emerg. Infect. Dis. 6:601-608.
34. Badovinac, V.P., A.R. Tvinnereim, and J.T. Harty. 2000. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferongamma. Science. 290:1354-1358.
35. Matloubian, M., M. Suresh, A. Glass, M. Galvan, K. Chow, J.K. Whitmire, C.M. Walsh, W.R. Clark, and R. Ahmed. 1999. A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 73:2527-2536.
36. Kagi, D., B. Odermatt, and T.W. Mak. 1999. Homeostatic regulation of CD8+ T cells by perforin. Eur. J. Immunol. 29:3262-3272.
37. Jordan, M.B., D. Hildeman, J. Kappler, and P. Marrack. 2004. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 104:735-743.
38. Henter, J.I., G. Elinder, and A. Ost. 1991. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin. Oncol. 18:29-33.
39. Henter, J.I., A. Horne, M. Arico, R.M. Egeler, A.H. Filipovich, S. Imashuku, S. Ladisch, K. McClain, D. Webb, J. Winiarski, and G. Janka. 2007. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer. 48:124-131.
40. Madison, J.M., S. Nurrish, and J.M. Kaplan. 2005. UNC-13 interaction with syntaxin is required for synaptic transmission. Curr. Biol. 15:2236-2242.
41. Brose, N., K. Hofmann, Y. Hata, and T.C. Sudhof. 1995. Mammalian homologues of Caenorhabditis elegans unc-13 gene define novel family of C2-domain proteins. J. Biol. Chem. 270:25273-25280.
42. Ahmed, S., I.N. Maruyama, R. Kozma, J. Lee, S. Brenner, and L. Lim. 1992. The Caenorhabditis elegans unc-13 gene product is a phospholipid-dependent high-affinity phorbol ester receptor. Biochem. J. 287:995-999.
43. Augustin, I., C. Rosenmund, T.C. Sudhof, and N. Brose. 1999. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature. 400:457-461.
44. Varoqueaux, F., A. Sigler, J.S. Rhee, N. Brose, C. Enk, K. Reim, and C. Rosenmund. 2002. Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming. Proc. Natl. Acad. Sci. USA. 99:9037-9042.
45. Augustin, I., S. Korte, M. Rickmann, H.A. Kretzschmar, T.C. Sudhof, J.W. Herms, and N. Brose. 2001. The cerebellum-specific Munc13 isoform Munc13-3 regulates cerebellar synaptic transmission and motor learning in mice. J. Neurosci. 21:10-17.
46. Varoqueaux, F., M.S. Sons, J.J. Plomp, and N. Brose. 2005. Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse. Mol. Cell. Biol. 25:5973-5984.
47. Verhage, M., A.S. Maia, J.J. Plomp, A.B. Brussaard, J.H. Heeroma, H. Vermeer, R.F. Toonen, R.E. Hammer, T.K. van den Berg, M. Missler, et al. 2000. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science. 287:864-869.
48. Shirakawa, R., T. Higashi, A. Tabuchi, A. Yoshioka, H. Nishioka, M. Fukuda, T. Kita, and H. Horiuchi. 2004. Munc13-4 is a GTP-Rab27-binding protein regulating dense core granule secretion in platelets. J. Biol. Chem. 279:10730-10737.
49. Bossi, G., and G.M. Griffiths. 1999. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5:90-96.
50. Blott, E.J., and G.M. Griffiths. 2002. Secretory lysosomes. Nat. Rev. Mol. Cell Biol. 3:122-131.
51. Du, X., K. Tabeta, K. Hoebe, H. Liu, N. Mann, S. Mudd, K. Crozat, S. Sovath, X. Gong, and B. Beutler. 2004. Velvet, a dominant Egfr mutation that causes wavy hair and defective eyelid development in mice. Genetics. 166:331-340.
52. Orange, J.S., B. Wang, C. Terhorst, and C.A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
53. Dutko, F.J., and M.B. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.